October 21, 2021 ( Washington, DC/Boston, Mass) — Reginald Swift, CEO of Rubix Life Science named Boston Business Journal Power 50 – “The Movement Makers.” Swift along with the other honorees, was recognized for leadership in creating change and taking...
Local Clinical Research Facility in Lawrence, MassachusettsUnveils Plans to Build Clinical Trial Site for Under-represented Communities Rubix LS unveils a plan for a 40,000 sq. ft site centrally located in Lawrence, Mass.to focus on clinical therapeutic research needs...
November 7, 2020, Lawrence, MA – Rubix LS has announced today that it is nearly halfway towards it funding goal of $1M, at $450,000, for its lead platform, StarSense, a virtual clinical trial platform that has been piloted in the utility of patient testing for...
Recently our Founder and CEO, Reginald Swift, sat down with the team at Pharma Tech Outlook magazine to discuss the changes happening with the pharma industry and how digital health, particularly virtual clinical trials are mobilizing access of pipeline therapeutics...
